The JAK2 pathway is activated in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

Published:2018-02-06 Issue:1 Volume:19 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Milara Javier,Hernandez Gracia,Ballester Beatriz,Morell Anselm,Roger Inés,Montero P.,Escrivá Juan,Lloris José M.,Molina-Molina Maria,Morcillo Esteban,Cortijo Julio

Funder

Ministerio de Educación, Cultura y Deporte

Instituto de Salud Carlos III

CIBERES

Ministerio de Economía y Competitividad

Generalitat Valenciana

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-018-0728-9.pdf

Reference36 articles.

1. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19.

2. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9:157–79.

3. Bagnato G, Harari S. Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev. 2015;24:102–14.

4. Jagadapillai R, Rane MJ, Lin X, Roberts AM, Hoyle GW, Cai L, Gozal E. Diabetic microvascular disease and pulmonary fibrosis: the contribution of platelets and systemic inflammation. Int J Mol Sci. 2016;17.

5. Chaudhary NI, Roth GJ, Hilberg F, Muller-Quernheim J, Prasse A, Zissel G, Schnapp A, Park JE. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29:976–85.

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11

2. Xuanfei Baidu Decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFNγ/STAT1/STAT3 axis;Phytomedicine;2024-09

3. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis;Autoimmunity Reviews;2024-09

4. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

5. Causal relationship between serum metabolites and idiopathic pulmonary fibrosis: Insights from a two-sample Mendelian randomization study;Heliyon;2024-08